Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 15 of 382 for:    IFNA2 AND RBV AND genotype

Combination Therapy With Pegylated Interferon and Ribavirin in Patients With Chronic Hepatitis C Genotype 2 or 3 Infection Who Previously Have Relapsed After Therapy With Pegylated Interferon and Ribavirin (RelapC)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT00641654
Recruitment Status : Terminated (Recruitment problems in Denmark and Norway)
First Posted : March 24, 2008
Last Update Posted : August 30, 2012
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Göteborg University

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Terminated
Actual Primary Completion Date : December 2009
Actual Study Completion Date : December 2009